We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




New AI-driven Toolkit Provides Insight into Infectious Pathogens

By LabMedica International staff writers
Posted on 20 Mar 2019
Scientists at the Francis Crick Institute (London, England) and UCL (London, England) have developed a new AI-driven platform that can analyze how pathogens infect human (‘host’) cells with the precision of a trained biologist.

The platform named HRMAn (‘Herman’), which stands for Host Response to Microbe Analysis, is open-source, easy-to-use and can be tailored for different pathogens including Salmonella enterica. More...
HRMAn uses deep neural networks to analyze complex patterns in images of pathogen and human cell interactions, pulling out the same detailed characteristics that scientists do by-hand.

The researchers used HRMAn to analyze the body’s response to Toxoplasma gondii, a parasite that replicates in cats and is thought to be carried by more than a third of the world’s population. Researchers in the Crick’s High Throughput Screening facility collected over 30,000 microscope images of five different types of Toxoplasma-infected human cells and loaded them into HRMAn for analysis. HRMAn detected and analyzed over 175,000 pathogen-containing cellular compartments, providing detailed information about the number of parasites per cell, the location of the parasites within the cells, and how many cell proteins interacted with the parasites, among other variables. The team also used HRMAn to analyze Salmonella enterica – a bacterial pathogen 16 times smaller than Toxoplasma, demonstrating its versatility for studying different pathogens.

“What used to be a manual, time-consuming task for biologists now takes us a matter of minutes on a computer, enabling us to learn more about infectious pathogens and how our bodies respond to them, more quickly and more precisely,” said Eva Frickel, Group Leader at the Crick, who led the project. “HRMAn can actually see host-pathogen interactions like a biologist, but unlike us, it doesn’t get tired and need to sleep!”

“Using the same sorts of algorithms that run self-driving cars, we’ve created a platform that boosts the precision of high volume biological data analysis, which has revolutionized what we can do in the lab,” said Artur Yakimovich, Research Associate in Jason Mercer’s lab at the MRC LMCB at UCL and co-first author of the study. Algorithms come in handy when the platform evaluates the image-based data in a way a trained specialist would. It’s also really easy to use, even for scientists with little to no knowledge of coding.”

Related Links:
Francis Crick Institute
UCL


Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Real-Time PCR System
Gentier 96T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.